Sudden cardiac death risk falls in colorectal cancer, but disparities persist
“Persistent discrepancies by gender, race, and geography underline the importance of individualized cardio-oncology surveillance, equitable preventative initiatives, and focused public health interventions”
2025-12-04
(Press-News.org)
“Persistent discrepancies by gender, race, and geography underline the importance of individualized cardio-oncology surveillance, equitable preventative initiatives, and focused public health interventions.”
BUFFALO, NY — December 4, 2025 — A new research paper was published in Volume 12 of Oncoscience on November 7, 2025, titled “Temporal trends and disparities in sudden cardiac death among colorectal cancer patients: A nationwide study.”
In this study, led by first author Eric Sanji of Magnolia Regional Health Center, researchers examined how often sudden cardiac death (SCD) occurs in people with colorectal cancer (CRC) in the United States (U.S.). They found that while the overall risk has declined over the past two decades, differences remain based on race, sex, and geographic location. These findings point to the need for more tailored heart monitoring and care strategies for cancer patients.
Colorectal cancer is one of the most common causes of cancer-related deaths worldwide. Advances in screening and treatment have improved survival rates, but many long-term survivors still face other health risks, particularly those related to the heart. Sudden cardiac death is an emerging concern in this population due to the combined effects of aging, pre-existing heart conditions, and side effects from cancer treatments.
To explore this issue, researchers analyzed U.S. death records from 1999 to 2020 using data from the CDC WONDER Multiple Cause of Death database. They studied over two decades of trends in SCD among CRC patients, analyzing rates by age, sex, race/ethnicity, and state.
“Colorectal cancer (CRC) fatalities were identified using ICD-10 codes C18–C21, and sudden cardiac death (SCD) was defined using ICD-10 codes I46.1, I46.9, R96.0, I49.0, and I21–I24.”
The study showed that the age-adjusted death rate for SCD among CRC patients decreased from 1.2 per 100,000 people in 1999 to 0.5 in 2020. This decline reflects improvements in both cancer care and heart disease prevention. However, not all groups benefited equally. Black and Asian/Pacific Islander patients had consistently higher SCD mortality rates than White patients. Male patients also faced a greater risk than females. Regionally, states like Nebraska and Vermont recorded higher per capita death rates, while populous states such as California and Texas showed lower rates.
The highest burden of SCD was found in patients aged 65 to 84, an age group that often has multiple cardiovascular risk factors. The researchers suggest that heart complications in this population may be linked to the aging process, coexisting conditions, and cardiotoxicity of cancer treatments, which are known to increase the risk of fatal heart rhythms.
While the overall decline in SCD is a positive trend, the researchers emphasize that persistent disparities highlight gaps in access to care and prevention. Socioeconomic differences, healthcare inequality, and systemic barriers may contribute to these outcomes. The study also reinforces the need for equitable cardio-oncology strategies, improved surveillance during and after cancer treatment, and public health interventions that address the specific risks faced by underserved groups.
Overall, this research contributes to the growing field of cardio-oncology and highlights the importance of integrating cardiovascular care into long-term cancer treatment planning, especially for aging and vulnerable populations.
DOI: https://doi.org/10.18632/oncoscience.635
Correspondence to: Eric Sanji – sanjieric06@gmail.com, esanji@mrhc.org
Abstract video: https://www.youtube.com/watch?v=lxi3TwB3BYQ
Keywords: cancer, racial disparities, sudden cardiac death, colorectal cancer, cancer mortality, cardio-oncology
Click here to sign up for free Altmetric alerts about this article.
About Oncoscience:
Oncoscience is a peer-reviewed, open-access, traditional journal covering the rapidly growing field of cancer research, especially emergent topics not currently covered by other journals. This journal has a special mission: Freeing oncology from publication costs. It is free for the readers and the authors.
Oncoscience is indexed and archived by PubMed, PubMed Central, Scopus, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncoscience, visit Oncoscience.us and connect with us on social media:
X
Instagram
Facebook
YouTube
LinkedIn
For media inquiries, please contact media@impactjournals.com.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-12-04
Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope to ovarian cancer patients who do not respond to existing treatments. Conducted entirely at the University of Colorado Anschutz, this research has advanced from the laboratory to a Phase 1 clinical trial on the campus.
The findings, published today in Cancer Research Communications, outline a promising strategy that combines a PARP inhibitor, a targeted drug used to treat certain types of ovarian cancer, with ...
2025-12-04
PLYMOUTH MEETING, PA [December 4, 2025] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers that publishes free evidence-based, expert consensus-driven guidelines for cancer prevention and care—today announced the hiring of Renuka Iyer, MD, as the new Chief Medical Officer (CMO) for the organization.
Dr. Iyer has a long history of leadership and innovation in oncology. She currently serves as a Professor of Oncology for Roswell Park Comprehensive ...
2025-12-04
Los Angeles, CA – December 4, 2025 – Dr. Vadim Jucaud’s lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing.
Immunosenescence, the natural decline of the immune system with age, significantly reduces the effectiveness of cancer vaccines. Yet, despite its clinical importance, age-related immune decline is seldom incorporated into vaccine development pipelines. Current 2D ...
2025-12-04
Europe is gobbling up almost 50 square metres of land and topsoil per second. And Norway tops the list of European countries with the most land lost to construction per person, according to a study initiated by the Arena for Journalism in Europe and the Norwegian Broadcasting Corporation, NRK. At the same time, we have never had access to more data and knowledge about nature and the ecosystems we are building on.
"We are acquiring more and more ecological data as a basis for land-use planning. Then you would think that the decisions we make ...
2025-12-04
In newly published research, Binghamton University doctoral student Elana Israel, MS ’22, explores which depressive symptoms largely affect children’s neural responses to feedback.
Depression in parents can affect a child’s reward processing, or how their brains react to positive and negative feedback. Israel and Psychology Professor Brandon Gibb, director of the Mood Disorders Institute, explored whether a specific symptom of depression in parents known as anhedonia, a loss of interest or pleasure in things, may be specifically responsible for this link. The study will be included in ...
2025-12-04
Ambiguous speech production is a common challenge for learners of a second language (L2), but identifying whether the problem lies in pronunciation or deeper linguistic processing is not always straightforward. A new study conducted by Professor Sylvain Detey from Waseda University, with Dr. Verdiana De Fino from IRIT, UT3, University of Toulouse & Archean Labs, France, and Dr. Lionel Fontan, Head of Archean Labs, France, sheds light on this distinction. Their study was published on October 30, 2025, in the journal Language Testing in Asia.
The researchers sought to determine whether ambiguous speech errors made by Japanese learners of French could be better categorized through a combined ...
2025-12-04
Advances in materials science have led to the development of “smart materials,” whose properties do not remain static but change in response to external stimuli. One such material is poly(N-isopropylacrylamide), or PNIPAM, a polymer gel that alters its solubility with temperature. The polymer contains hydrophilic amide groups and hydrophobic isopropyl groups. At low temperatures, the amide groups form strong hydrogen bonds with water, keeping the material well-swollen and soluble. However, as the temperature increases, these hydrogen bonds weaken while ...
2025-12-04
Extracellular vesicles (EVs) have rapidly emerged as one of the most promising frontiers in modern biology. These nano-sized messengers mediate communication between cells, tissues, and organs, influencing processes from immune signaling to cancer progression. Their growing diagnostic, prognostic, and therapeutic relevance has accelerated research worldwide. Yet one major limitation persists: the absence of efficient, scalable, and equipment-independent EV isolation methods. Existing techniques, including ultracentrifugation and size-exclusion chromatography (SEC), remain labor-intensive, instrumentation-heavy, and unsuitable for processing large-volume biofluids.
To ...
2025-12-04
Nicotine addiction remains one of the most persistent public health challenges worldwide, driven by changes in the brain that reinforce repeated use and make quitting extremely difficult. For decades, scientists have focused primarily on neurons to explain how these changes occur. But growing evidence suggests that other brain cells may play a far more active role in shaping addictive behavior than previously thought.
Building on this shift in understanding, a team of researchers led by Professor Eun Sang Choe from the Department of Biological Sciences, Pusan National ...
2025-12-04
A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer. This subtype accounts for 70% of breast cancer cases, and despite effective treatments, it causes the highest mortality in total cases. Additionally, immunotherapy is not effective or approved because it shows no immune system response in these tumors, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Sudden cardiac death risk falls in colorectal cancer, but disparities persist
“Persistent discrepancies by gender, race, and geography underline the importance of individualized cardio-oncology surveillance, equitable preventative initiatives, and focused public health interventions”
